Understanding Loss to Follow-Up in AMD Patients Receiving VEGF Inhibitor Therapy: Associated Factors and Underlying Reasons

血管内皮生长因子受体 医学 内科学 肿瘤科
作者
Pavol Kusenda,Martin Čaprnda,Zuzana Gabrielova,Natalia Kukova,Sanja Pavlović,Jana Štefaničková
出处
期刊:Diagnostics [MDPI AG]
卷期号:14 (4): 400-400
标识
DOI:10.3390/diagnostics14040400
摘要

Background: In patients with wet age-related macular degeneration (AMD), loss to follow-up (LTFU) leads to unplanned interruptions in therapy and the risk of visual loss. Methods: This retrospective and prospective case–control cohort study compared AMD patients with (LTFU YES) and without (LTFU NO) LTFU during anti-VEGF treatment over 12 years. LTFU was defined as missing any treatment or monitoring visits, or not scheduling follow-ups for six months. Results: Significant differences between LTFU NO (n = 298) and LTFU YES (n = 174) groups were age, treatment phase, baseline and final best-corrected visual acuity (BCVA), type of anti-VEGF drug, treatment switch, commuting distance, and escort during commuting. A multivariate logistic regression analysis identified the need for an escort during the commuting and treatment phase as the only significant difference. The four most common reasons for LTFU were general health worsening (21.8%), patient-missed appointments (16.7%), COVID-19-related issues (14.9%), and treatment dissatisfaction (8.6%). Conclusions: The factors associated with increased LTFU rates were older age, inactive treatment phase, lower baseline and final BCVA, bevacizumab treatment, monotherapy, longer travelling distance, and commuting with an escort. According to the multivariate logistic regression analysis, only the escort during the commuting and treatment phases was significant. These findings could direct research to explore social support in treatment adherence and highlight the importance of treatment phases in practice.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
医路前行完成签到,获得积分10
刚刚
科研通AI2S应助虚幻泽洋采纳,获得10
刚刚
算我运气好完成签到,获得积分10
1秒前
1秒前
zmuzhang2019完成签到,获得积分10
4秒前
清脆的秋寒完成签到,获得积分10
5秒前
zmuzhang2019发布了新的文献求助10
6秒前
小小菜鸟完成签到,获得积分10
8秒前
α(阿尔法)完成签到 ,获得积分10
10秒前
14秒前
同學你該吃藥了完成签到 ,获得积分10
17秒前
曾建完成签到 ,获得积分10
18秒前
yt完成签到,获得积分10
20秒前
king19861119完成签到,获得积分10
23秒前
小绵羊完成签到,获得积分20
23秒前
lbx完成签到,获得积分10
26秒前
星辰大海应助asdad采纳,获得10
26秒前
努力的学完成签到,获得积分10
27秒前
PDIF-CN2完成签到,获得积分10
27秒前
111发布了新的文献求助50
31秒前
星辰完成签到,获得积分10
33秒前
38秒前
少年完成签到,获得积分10
38秒前
asdad完成签到,获得积分10
38秒前
独徙完成签到 ,获得积分10
38秒前
Menand完成签到,获得积分10
41秒前
asdad发布了新的文献求助10
41秒前
42秒前
yxm完成签到 ,获得积分10
42秒前
bkagyin应助勇往直前采纳,获得10
44秒前
44秒前
小绵羊发布了新的文献求助10
49秒前
50秒前
JamesPei应助科研通管家采纳,获得10
51秒前
思南欧应助科研通管家采纳,获得20
51秒前
深情安青应助科研通管家采纳,获得10
51秒前
科研通AI2S应助科研通管家采纳,获得10
51秒前
huhuhuuh应助科研通管家采纳,获得50
52秒前
Dobby完成签到,获得积分10
54秒前
全问筠应助咚咚锵@思密达采纳,获得10
54秒前
高分求助中
Un calendrier babylonien des travaux, des signes et des mois: Séries iqqur îpuš 1036
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 1000
Corrosion and Oxygen Control 600
Python Programming for Linguistics and Digital Humanities: Applications for Text-Focused Fields 500
Heterocyclic Stilbene and Bibenzyl Derivatives in Liverworts: Distribution, Structures, Total Synthesis and Biological Activity 500
重庆市新能源汽车产业大数据招商指南(两链两图两池两库两平台两清单两报告) 400
Division and square root. Digit-recurrence algorithms and implementations 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2546297
求助须知:如何正确求助?哪些是违规求助? 2175702
关于积分的说明 5600550
捐赠科研通 1896461
什么是DOI,文献DOI怎么找? 946308
版权声明 565379
科研通“疑难数据库(出版商)”最低求助积分说明 503557